PET evaluation of fatty tumors in the extremity: Possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcoma

Annals of Nuclear Medicine

Volumn 19, Issue 8, 2005, Pages 661-670

  Suzuki, Ryoko ^a   Watanabe, Hideomi ^a   Yanagawa, Takashi ^a   Sato, Junko ^a   Shinozaki, Tetsuya ^a   Suzuki, Hideki ^a   Endo, Keigo ^a   Takagishi, Kenji ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

FDG PET; FMT PET; Lipoma; Liposarcoma; Subtype

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STANDARDIZATION;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEASIBILITY STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIPOMA; LIPOSARCOMA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TYROSINE;

EID: 31744435551     PISSN: 09147187     EISSN: 09147187     Source Type: Journal    
DOI: 10.1007/BF02985114     Document Type: Article

References (26)

1. Enzinger FM, Weiss SW. Benign lipomatous tumors. In: Enzinger FM, Weiss SW (eds). Soft tissue tumors. St. Louis; Mosby, 1995: 381-430.
2. Weiss SW. Lipomatous tumors. In: Weiss SW, Brooks JSJ (eds). Soft tissue tumors. Baltimore; Williams & Wilkins, 1996: 207-251.
3. Enzinger FM, Weiss SW. Liposarcoma. In: Enzinger FM, Weiss SW (eds). Soft tissue tumors. St. Louis; Mosby, 1995: 431-466.
4. Hashimoto H, Enjoji M. Liposarcoma: a clinicopathologic subtyping of 52 cases. Acta Pathol Jpn 1982; 32: 933-939.
5. Kransdorf MJ, Bancroft LW, Peterson JJ, Murphey MD, Foster WC, Temple HT. Imaging of fatty tumors: Distinction of lipoma and well-differentiated liposarcoma. Radiology 2002; 224: 99-104.
6. Adler LP, Blair HF, Makley JT, Williams RP, Joyce MJ, Leisure G, et al. Noninvasive grading of musculoskeletal tumors using PET. J Nucl Med 1991; 32: 1508-1512.
7. Kern KA, Brunetti A, Norton JA, Chang AE, Malawer M, Lack E, et al. Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med 1988; 29: 181-186.
8. Nieweg OE, Pruim J, van Ginkel RJ, Hoekstra HJ, Paans AMJ, Molenaar WM, et al. Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med 1996; 37: 257-261.
9. Griffeth LK, Dehdashti F, McGuire AH, McGuire DJ, Perry D, Moerlein SM, et al. PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose. Radiology 1992; 182: 185-194.
10. Watanabe H, Shinozaki T, Yanagawa T, Aoki J, Tokunaga M, Inoue T, et al. Glucose metabolic analysis of musculoskeletal tumors using Fluorine-18-FDG PET as an aid to preoperative planning. J Bone Joint Surg [Br] 2000; 82-B: 760-767.
11. Kole AC, Nieweg OE, Hoekstra HJ, van Horn JR, Koops HS, Vaalburg W. Fluorine-18-fluorodeoxyglucose assessment of glucose metabolism in bone tumors. J Nucl Med 1998; 39: 810-815.
12. Watanabe H, Inoue T, Shinozaki T, Yanagawa T, Oriuchi N, Ahmed AR, et al. PET imaging of musculoskeletal tumors with F-18 alpha-methyltyrosine: Comparison with F-18 fluorodeoxyglucose PET. Eur J Nucl Med 2000; 27: 1509-1517.
13. Ahmed AR, Watanabe H, Aoki J, Shinozaki T, Takagishi K. Schwannoma of the extremities: The role of PET in the preoperative planning. Eur J Nucl Med 2001; 28: 1541-1551.
14. Yanagawa T, Watanabe H, Inoue T, Ahmed AR, Tomiyoshi K, Shinozaki T, et al. Carbon-11 choline PET in musculoskeletal tumors: Comparison with fluorine-18 fluorodeoxyglucose PET. J Comput Assoc Tomograph 2003; 27: 175-182.
15. Hatayama K, Watanabe H, Ahmed AR, Yanagawa T, Shinozaki T, Oriuchi N, et al. Evaluation of hemangioma by PET: A role in multi-modality approach. J Comput Assoc Tomograph 2003; 27: 70-77.
16. Einarsdottir H, Soderlund V, Larsson O, Mandahl N, Bauer HC. 110 subfascial lipomatous tumors. MR and CT findings versus histopathological diagnosis and cytogenetic analysis. Acta Radiol 1999; 40: 603-609.
17. Hanley JA, McNeil BJ. The meaning and use of the area under a receiving operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
18. Hanley JA, McNeil BJ. A method of comparing the areas under receiving operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-843.
19. Jelinek JS, Kransdorf MJ, Shmookler BM, Aboulafia AJ, Malawer MM. Liposarcoma of the extremities: MR and CT findings in histologic subtypes. Radiology 1993; 186: 455-459.
20. Arkun R, Memis A, Akalin T, Ustun EE, Sabah D, Kandiloglu G. Liposarcoma of soft tissue: MRI findings with pathologic correlation. Skeletal Radiol 1997; 26: 167-172.
21. Munk PL, Lee MJ, Janzen DL, Connell DG, Logan PM, Poon PY, et al. Lipoma and Liposarcoma: Evaluation Using CT and MR imaging. Am J Roentgenol 1997; 169: 589-594.
22. Hosono M, Kobayashi H, Fujimoto R, Kotowa Y, Tsuboyama T, Matsusue Y, et al. Septum-like structure in lipoma and liposarcoma: MR imaging and pathologic correlation. Skeletal Radiol 1997; 26: 150-154.
23. Dehdashti F, Siegel BA, Griffeth LK, Fusselman MJ, Trask DD, McGuire AH, et al. Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology 1996; 200: 243-247.
24. Aoki J, Watanabe H, Shinozaki T, Tokunaga M, Inoue T, Endo K. FDG-PET in differential diagnosis and grading of chondrosarcomas. J Comput Assoc Tomograph 1999; 23: 603-608.
25. Hatano H, Ogose A, Hotta T, Kawashima H, Sugita T, Sasamoto R, et al. Treatment of myxoid liposarcoma by marginal or intralesional resection combined with radiotherapy. Anticancer Res 2003; 23: 3045-3049.
26. Barile A, Zugaro L, Catalucci A, Caulo M, Di Cesare E, Splendiani A, et al. Soft tissue liposarcoma: histological subtypes, MRI and CT findings. Radiol Med 2002; 104: 140-149.